Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for GUANFACINE

Ingredient

GUANFACINE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-GUANFACINE XR	2MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-07-22	2022-08-06	165317
APO-GUANFACINE XR	4MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-09-04	2025-09-12	266649
APO-GUANFACINE XR	4MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-12-15	2024-01-12	213559
APO-GUANFACINE XR	4MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-07-22	2022-08-06	165322
APO-GUANFACINE XR	3MG	TABLET (EXTENDED-RELEASE)	Resolved	2024-12-12	2025-01-17	245499
APO-GUANFACINE XR	3MG	TABLET (EXTENDED-RELEASE)	Resolved	2024-12-05	2025-01-17	244922
APO-GUANFACINE XR	3MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-12-22	2024-01-12	214220
APO-GUANFACINE XR	3MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-06-12	2022-07-28	162475
APO-GUANFACINE XR	2MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-06-26	2025-07-04	261170
APO-GUANFACINE XR	2MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-12-22	2024-01-12	214232

1
2
3
Next

Showing 1 to 10 of 21

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports

1

Showing 1 to 0 of 0